Pew Seeks FDA Subpoena Power, Harsher Counterfeiting Penalties to Fix Gaps in Global Oversight

The Pew Health Group is taking aim at FDA and industry oversight of foreign manufacturing, calling for increased agency authorities, such as the ability to mandate recalls and subpoena witnesses and documents.
Drug Industry Daily